Literature DB >> 33551794

PONV management in patients with QTc prolongation on the EKG.

S Soghomonyan1, N Stoicea1, W Ackermann1, S P Bhandary1.   

Abstract

Postoperative nausea and vomiting (PONV) is a commonly encountered problem in surgical practice. It delays discharge from the post-anesthesia care unit, requires additional resources to treat, and may increase the morbidity in some patients. Many effective drugs are available to treat or prevent PONV, however many of these drugs have the potential to prolong the QTc on the electrocardiogram (EKG) and increase the risk of serious ventricular arrhythmias, in particular, torsade de pointes. The QTc prolongation may be a manifestation of a genetic mutation resulting in abnormal myocyte repolarization or it may be acquired and associated with the use of various medications, electrolyte disorders, and physiological conditions. Patients predisposed to QTc prolongation presenting for surgery constitute a challenging group, since many drugs commonly used for PONV management will put them at risk for perioperative serious arrhythmias. This is an important topic, and our mini-review is an attempt to highlight the problem, summarize the existing experience, and generate recommendations for safe management of PONV for patients, who are at increased risk of QTc prolongation and arrhythmias. Focused prospective studies will help to find definitive answers to the discussed problems and challenges and develop specific guidelines for clinical application.
Copyright © 2021 Soghomonyan, Stoicea, Ackermann and Bhandary.

Entities:  

Keywords:  PONV; QTc; anesthesia; perioperative period; postoperative nausea and vomiting; torsade de pointes

Year:  2021        PMID: 33551794      PMCID: PMC7861054          DOI: 10.3389/fphar.2020.565704

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  21 in total

1.  Arrhythmia risk of antiemetic agents.

Authors:  Gareth S Kantor
Journal:  Anesthesiology       Date:  2002-07       Impact factor: 7.892

Review 2.  American Academy of Emergency Medicine Position Statement: Safety of Droperidol Use in the Emergency Department.

Authors:  Jack Perkins; Jeffrey D Ho; Gary M Vilke; Gerard DeMers
Journal:  J Emerg Med       Date:  2015-03-30       Impact factor: 1.484

3.  Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.

Authors:  Thomas C Marbury; Bo Jin; Deborah Panebianco; M Gail Murphy; Hong Sun; Judith K Evans; Tae H Han; Marvin L Constanzer; James Dru; Craig R Shadle
Journal:  Anesth Analg       Date:  2009-08       Impact factor: 5.108

Review 4.  Anesthetic Considerations for Pediatric Patients With Congenital Long QT Syndrome.

Authors:  Genevieve E Staudt; Scott C Watkins
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-11-12       Impact factor: 2.628

Review 5.  Haloperidol Versus 5-HT3 Receptor Antagonists for Postoperative Vomiting and QTc Prolongation: A Noninferiority Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.

Authors:  Preet Mohinder Singh; Anuradha Borle; Jeetinder Kaur Makkar; Anjan Trikha; David Fish; Ashish Sinha
Journal:  J Clin Pharmacol       Date:  2017-09-15       Impact factor: 3.126

6.  Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Authors:  Barbara J Drew; Michael J Ackerman; Marjorie Funk; W Brian Gibler; Paul Kligfield; Venu Menon; George J Philippides; Dan M Roden; Wojciech Zareba
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

7.  Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron.

Authors:  Beny Charbit; Pierre Albaladejo; Christian Funck-Brentano; Mathieu Legrand; Emmanuel Samain; Jean Marty
Journal:  Anesthesiology       Date:  2005-06       Impact factor: 7.892

Review 8.  Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting.

Authors:  Tong J Gan; Kumar G Belani; Sergio Bergese; Frances Chung; Pierre Diemunsch; Ashraf S Habib; Zhaosheng Jin; Anthony L Kovac; Tricia A Meyer; Richard D Urman; Christian C Apfel; Sabry Ayad; Linda Beagley; Keith Candiotti; Marina Englesakis; Traci L Hedrick; Peter Kranke; Samuel Lee; Daniel Lipman; Harold S Minkowitz; John Morton; Beverly K Philip
Journal:  Anesth Analg       Date:  2020-08       Impact factor: 5.108

Review 9.  5-Hydroxytryptamine3 receptor antagonists and cardiac side effects.

Authors:  Louise Brygger; Jørn Herrstedt
Journal:  Expert Opin Drug Saf       Date:  2014-09-06       Impact factor: 4.250

Review 10.  The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting.

Authors:  Chin-Chen Chu; Chung-Hsi Hsing; Ja-Ping Shieh; Chih-Chiang Chien; Chiu-Ming Ho; Jhi-Joung Wang
Journal:  Eur J Pharmacol       Date:  2013-11-01       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.